Addition of Atrasentan to Renin-Angiotensin System Blockade Reduces Albuminuria in Diabetic Nephropathy Full Text
Journal of the American Society of Nephrology,  Clinical Article

Kohan DE et al. - Atrasentan, at the doses tested i.e. 0.25, 0.75, or 1.75 mg daily, is generally safe and effective in reducing residual albuminuria and may ultimately improve renal outcomes in patients with type 2 diabetic nephropathy.

  • Authors examined the effect of atrasentan, a selective endothelin A receptor (ETAR) antagonist, on albuminuria.
  • This is a randomized, double-blind, placebo-controlled trial of subjects with diabetic nephropathy already receiving stable doses of renin-angiotensin system (RAS) inhibitors.
  • 89 subjects with eGFR >20 ml/min per 1.73 m2 and a urinary albumin-to-creatinine ratio (UACR) of 100 to 3000 mg/g to placebo or atrasentan (0.25, 0.75, or 1.75 mg daily) for 8 weeks were assigned.

  • Compared with placebo, atrasentan significantly reduced urinary albumin-to-creatinine ratio (UACR) only in the 0.75- and 1.75-mg groups (P = 0.001 and P = 0.011, respectively).
  • Compared with the 11% reduction in the geometric mean of the UACR from baseline to final observation in the placebo group during the study, the geometric mean of UACR decreased by 21, 42, and 35% in the 0.25-, 0.75-, and 1.75-mg atrasentan groups (P = 0.291, P = 0.023, and P = 0.073, respectively).
  • In the placebo group, 17% of subjects achieved >=40% reduction in UACR from baseline compared with 30, 50, and 38% in the 0.25-, 0.75-, and 1.75-mg atrasentan groups, respectively (P = 0.029 for 0.75 mg versus placebo).
  • Peripheral edema occurred in 9% of subjects receiving placebo and in 14, 18, and 46% of those receiving 0.25, 0.5, and 1.75 mg atrasentan, respectively (P = 0.007 for 1.75 mg versus placebo).

Please login or register to follow this author.
Are you sure you want to Unfollow this Author?
► Click here to access Full Text, PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Nephrology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Nephrology Articles

1 Low-dose rapamycin (sirolimus) effects in autosomal dominant polycystic kidney disease: An open-label randomized controlled pilot study Clinical Journal of the American Society of Nephrology, May 23, 2014    Clinical Article

2 A randomized comparison of 1-h sodium bicarbonate hydration versus standard peri-procedural saline hydration in patients with chronic kidney disease undergoing intravenous contrast-enhanced computerized tomography Nephrology Dialysis Transplantation, May 5, 2014    Clinical Article

3 Effects of turmeric on uremic pruritus in end stage renal disease patients: A double-blind randomized clinical trial Full Text Journal of Nephrology, March 21, 2014    Free full text    Clinical Article

4 Comparison of methylprednisolone plus prednisolone with prednisolone alone as initial treatment in adult-onset minimal change disease: A retrospective cohort study Clinical Journal of the American Society of Nephrology, June 11, 2014    Clinical Article

5 Uric acid levels, kidney function, and cardiovascular mortality in US adults: National health and nutrition examination survey (NHANES) 1988-1994 and 1999-2002 American Journal of Kidney Diseases, June 4, 2014    Clinical Article

6 First-year outcomes of incident peritoneal dialysis patients in the United States American Journal of Kidney Diseases, June 13, 2014    Clinical Article

7 The effect of continuous versus intermittent renal replacement therapy on the outcome of critically ill patients with acute renal failure (CONVINT): A prospective randomized controlled trial Critical Care, January 13, 2014    Clinical Article

8 Clinical approach to renal tubular acidosis in adult patients International Journal of Clinical Practice, March 1, 2011

9 Hot bath for the treatment of chronic renal failure Renal Failure, December 9, 2013    Clinical Article

10 Chlorthalidone for poorly controlled hypertension in chronic kidney disease: An interventional pilot study American Journal of Nephrology, February 12, 2014    Clinical Article

11 Effects of intensive blood pressure lowering on the progression of chronic kidney disease: a systematic review and meta-analysis Canadian Medical Association Journal, August 12, 2013    Evidence Based Medicine    Review Article    Clinical Article

12 Effect of l-carnitine therapy on patients in maintenance hemodialysis: A systematic review and meta-analysis Full Text Journal of Nephrology, May 14, 2014    Free full text    Evidence Based Medicine    Review Article

13 Acute kidney injury associated with high nephrotoxic medication exposure leads to chronic kidney disease after 6 months The Journal of Pediatrics, June 16, 2014    Clinical Article

14 Hypertension in hemodialysis patients treated with atenolol or lisinopril: A randomized controlled trial Nephrology Dialysis Transplantation, January 14, 2014    Clinical Article

15 Long-term effects of addition of mineralocorticoid receptor antagonist to angiotensin II receptor blocker in patients with diabetic nephropathy: A randomized clinical trial Nephrology Dialysis Transplantation, November 4, 2013    Clinical Article

16 Synergism between circulating tumor necrosis factor receptor 2 and HbA1c in determining renal decline during 5–18 years of follow-up in patients with type 1 diabetes and proteinuria Diabetes Care, June 6, 2014    Clinical Article

17 Spironolactone to prevent cardiovascular events in early-stage chronic kidney disease (STOP-CKD): study protocol for a randomized controlled pilot trial Full Text Trials, May 12, 2014    Free full text    Evidence Based Medicine    Clinical Article

18 Glomerular disease: The search goes on: suPAR is not the elusive FSGS factor Nature Reviews Nephrology, June 25, 2014    Review Article

19 Remote ischemic preconditioning for prevention of acute kidney injury: A meta-analysis of randomized controlled trials American Journal of Kidney Diseases, June 23, 2014    Evidence Based Medicine    Review Article

20 Effect of hemodiafiltration or hemofiltration compared with hemodialysis on mortality and cardiovascular disease in chronic kidney failure: A systematic review and meta-analysis of randomized trials American Journal of Kidney Diseases, April 1, 2014    Evidence Based Medicine    Review Article    Clinical Article

Indexed Journals in Nephrology: Kidney International, Hemodialysis International, Nephrology Dialysis Transplantationmore

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Connect with us, stay current.

Receive the latest mecial news
updates for free via email

Sign up!

Subscribe to our free RSS feeds:

Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More